Susquehanna International Group’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Susquehanna International Group’s Portfolio PGNX Stock Details PGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-65,909	Closed	-$250K	–	5326
2020 Q1	$250K	Buy	65,909 +16,961	+35%	+$64.3K	﹤0.01%	3602
2019 Q4	$249K	Sell	48,948 -45,646	-48%	-$232K	﹤0.01%	3312
2019 Q3	$478K	Sell	94,594 -55,859	-37%	-$282K	﹤0.01%	2965
2019 Q2	$928K	Buy	+150,453	New	+$928K	﹤0.01%	2157
2019 Q1	–	Sell	-343,974	Closed	-$1.45M	–	5112
2018 Q4	$1.45M	Buy	343,974 +107,007	+45%	+$450K	﹤0.01%	1198
2018 Q3	$1.49M	Sell	236,967 -10,024	-4%	-$62.9K	﹤0.01%	1165
2018 Q2	$1.99M	Sell	246,991 -140,593	-36%	-$1.13M	﹤0.01%	1030
2018 Q1	$2.89M	Buy	387,584 +162,883	+72%	+$1.21M	﹤0.01%	744
2017 Q4	$1.34M	Buy	224,701 +102,322	+84%	+$609K	﹤0.01%	1505
2017 Q3	$901K	Buy	+122,379	New	+$901K	﹤0.01%	1737
2017 Q2	–	Sell	-137,223	Closed	-$1.3M	–	4733
2017 Q1	$1.3M	Sell	137,223 -60,393	-31%	-$570K	﹤0.01%	1431
2016 Q4	$1.71M	Buy	197,616 +183,938	+1,345%	+$1.59M	﹤0.01%	1674
2016 Q3	$87K	Buy	+13,678	New	+$87K	﹤0.01%	2722
2016 Q2	–	Sell	-57,326	Closed	-$250K	–	4427
2016 Q1	$250K	Buy	57,326 +23,590	+70%	+$103K	﹤0.01%	3161
2015 Q4	$207K	Sell	33,736 -84,606	-71%	-$519K	﹤0.01%	3726
2015 Q3	$677K	Sell	118,342 -119,434	-50%	-$683K	﹤0.01%	2836
2015 Q2	$1.77M	Buy	237,776 +69,895	+42%	+$521K	﹤0.01%	2000
2015 Q1	$1M	Sell	167,881 -87,107	-34%	-$521K	﹤0.01%	2439
2014 Q4	$1.93M	Buy	254,988 +201,652	+378%	+$1.52M	﹤0.01%	1907
2014 Q3	$277K	Sell	53,336 -52,776	-50%	-$274K	﹤0.01%	3308
2014 Q2	$457K	Sell	106,112 -12,829	-11%	-$55.3K	﹤0.01%	3214
2014 Q1	$486K	Sell	118,941 -52,999	-31%	-$217K	﹤0.01%	2643
2013 Q4	$916K	Buy	171,940 +123,983	+259%	+$661K	﹤0.01%	2318
2013 Q3	$241K	Buy	+47,957	New	+$241K	﹤0.01%	3078
2013 Q2	–	Hold	0	–	–	–	3781